Cardiology FDA Approved Structural Heart

Edwards’ KONECT RESILIA Aortic Valved Conduit Wins FDA Approval For Bio-Bentalls

Released on July 15, 2020

Edwards Lifesciences won FDA approval for its KONECT RESILIA aortic valved conduit, a device designed specifically for performing bio-Bentall procedures. Typically, […]

Read more
Cardiology MedTech Structural Heart

Edwards to pay Abbott $468M to settle mitral, tricuspid repair device patent dispute

Released on July 14, 2020

Dive Brief: Edwards Lifesciences has agreed to pay Abbott $368 million upfront to settle disputes over patents for transcatheter mitral and […]

Read more
Cardiology MedTech Structural Heart

Abiomed touts results of U.S. study of its latest Impella heart pump

Released on July 1, 2020

Abiomed (NSDQ:ABMD) says a study of U.S. patients receiving the new Impella 5.5 with SmartAssist found that 84% survived to explant and […]

Read more
Cardiology MedTech Structural Heart

CMS proposes major market expansion in potential boost for Abbott’s MitraClip

Released on July 1, 2020

Dive Brief: The Centers for Medicare and Medicaid Services has proposed expanding coverage of transcatheter mitral valve repair (TMVR) to take […]

Read more
Cardiology Funding Structural Heart

Polares raises $40M to target competitive mitral regurgitation market

Released on June 26, 2020

Dive Brief: Polares Medical has raised $40 million to pursue a fast-growing cardiovascular opportunity targeted by Abbott, Boston Scientific, Edwards Lifesciences […]

Read more
Cardiology MedTech Structural Heart

Abbott touts new data for its minimally invasive structural heart therapies

Released on June 25, 2020

Abbott (NYSE:ABT) today announced late-breaking data on some of its structural heart disease products. The data listed findings on the MitraClip system […]

Read more
Cardiology CE Mark Structural Heart

Medtronic Moves the Needle in TAVI with New Indication

Released on June 23, 2020

Medtronic has received CE mark for an expanded indication of its Evolut Transcatheter Aortic Valve Implantation system. The Dublin-based company said […]

Read more
Cardiology CE Mark Structural Heart

Medtronic Evolut TAVR system gets expanded label in Europe

Released on June 23, 2020

Dive Brief: Medtronic’s Evolut transcatheter aortic valve implantation system now has an expanded CE mark to treat patients with severe aortic […]

Read more
Cardiology CE Mark Structural Heart

Medtronic wins CE mark for TAVI system in low-risk patients

Released on June 22, 2020

Medtronic (NYSE:MDT) announced today that it received CE Mark approval for its Evolut transcatheter aortic valve implantation (TAVI) system. Evolut TAVI, now […]

Read more
Cardiology Funding Structural Heart

Foldax closes $20m Series D

Released on June 22, 2020

Heart valve designer and manufacturer Foldax announced today that it closed a Series D funding round with proceeds of $20 million. MemorialCare Innovation […]

Read more
Cardiology Public Offering Structural Heart

CryoLife announces $100m offering

Released on June 18, 2020

CryoLife Inc. (NYSE:CRY) announced today that it intends to offer a private placement of convertible senior notes worth $100 million. The Atlanta-based […]

Read more
Cardiology MedTech Structural Heart

Edwards Lifesciences wins approval in China for Sapien 3

Released on June 8, 2020

Edwards Lifesciences (NYSE:EW) announced today that it received regulatory approval in China for its Sapien 3 transcatheter heart valve. Sapien 3 TAVR […]

Read more